Review

Nature Reviews Drug Discovery 6, 891-903 (November 2007) | doi:10.1038/nrd2410

Target deconvolution strategies in drug discovery

Georg C. Terstappen1, Christina Schlüpen1, Roberto Raggiaschi1 & Giovanni Gaviraghi1  About the authors

Top

Recognition of some of the limitations of target-based drug discovery has recently led to the renaissance of a more holistic approach in which complex biological systems are investigated for phenotypic changes upon exposure to small molecules. The subsequent identification of the molecular targets that underlie an observed phenotypic response — termed target deconvolution — is an important aspect of current drug discovery, as knowledge of the molecular targets will greatly aid drug development. Here, the broad panel of experimental strategies that can be applied to target deconvolution is critically reviewed.

Author affiliations

  1. Siena Biotech S.p.A., Via Fiorentina 1, 53100 Siena, Italy.

Correspondence to: Georg C. Terstappen1 Email: gterstappen@sienabiotech.com

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

Open Innovation Challenges

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

  • Mitigating Zinc Corrosion

    • Deadline: Aug 23 2009
    • Reward: $20,000 USD

    The Seeker is looking for novel methods to mitigate zinc corrosion/gassing in alkaline media. This ...

naturejobs

natureproducts


Advertisement